 
        
        
        
                货号:A906431
                
                同义名:
                    
                        
                            
                                8-Oxoberberine; Berlambine
                            
                        
                    
                
                
                
                    
                     
                
            
Oxyberberine是从植物提取的天然生物碱,表现出抗癌活性,尤其在 SW480 结肠癌细胞系研究中具有显著作用,可作为抗肿瘤候选化合物研究的基础。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| Concentration | Treated Time | Description | References | |
| Human colonic Caco-2 cells | 10 µM, 20 µM, 40 µM | 24 hours | To evaluate the protective effect of OBB on LPS-induced barrier dysfunction in Caco-2 cells. Results showed that OBB improved TEER values, reduced FITC-dextran flux, and upregulated the expression of tight junction proteins ZO-1, occludin, and E-cadherin. | Front Pharmacol. 2025 Jan 7;15:1496874 | 
| RAW 264.7 macrophages | 0.1, 0.2, 0.4 µM | 24 hours | To evaluate the effect of OBB on LPS-induced secretion of inflammatory cytokines TNF-α, IL-6, and IL-18. Results showed that OBB significantly suppressed the secretion of these cytokines, and 0.4 μM OBB had comparable effects to 5 μM BBR. | Drug Des Devel Ther. 2022 Dec 23;16:4365-4383 | 
| RAW 264.7 macrophages | 2.5, 5, 10, 20, 40, 80 µM | 24 hours | To evaluate the cytotoxic effect of OBB and BBR on RAW 264.7 macrophages. Results showed that OBB exhibited no significant inhibition on cell growth at concentrations ranging from 2.5 to 80 μM, while BBR showed toxicity at 80 μM. | Drug Des Devel Ther. 2022 Dec 23;16:4365-4383 | 
| Huh7 | 1, 5, 10, 50, 100 µM | 48 hours | OBB significantly inhibited USP7 expression in a dose-dependent manner. | Hepatol Commun. 2024 Mar 29;8(4):e0405 | 
| Hep3B | 1, 5, 10, 50, 100 µM | 48 hours | OBB significantly inhibited USP7 expression in a dose-dependent manner. | Hepatol Commun. 2024 Mar 29;8(4):e0405 | 
| Administration | Dosage | Frequency | Description | References | ||
| Kunming mice | Acetic acid-induced vascular permeability mice model | Oral | 1, 2, 4 mg/kg | For 7 consecutive days | To evaluate the effect of OBB on acetic acid-induced vascular permeability. Results showed that OBB significantly suppressed vascular permeability in a dose-dependent manner, and 2 mg/kg OBB was as effective as 20 mg/kg BBR. | Drug Des Devel Ther. 2022 Dec 23;16:4365-4383 | 
| Sprague Dawley rats | Hyperuricemia model | Oral | 50 mg/kg | Single dose | To evaluate the pharmacokinetic properties of OBB-HP-β-CD SDDS, results showed its AUC0-t and Cmax were significantly higher than OBB raw material | Int J Nanomedicine. 2024 Jun 6;19:5297-5316 | 
| BALB/c nude mice | Liver cancer xenograft model | Intraperitoneal injection (OBB), oral gavage (sorafenib) | OBB (10 mg/kg), sorafenib (30 mg/kg) | Daily administration for 5 days followed by 2 days rest, lasting 31 days | Combination treatment with OBB and sorafenib significantly inhibited the growth of liver cancer xenografts. | Hepatol Commun. 2024 Mar 29;8(4):e0405 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.85mL 0.57mL 0.28mL | 14.23mL 2.85mL 1.42mL | 28.46mL 5.69mL 2.85mL | |
| CAS号 | 549-21-3 | 
| 分子式 | C20H17NO5 | 
| 分子量 | 351.35 | 
| SMILES Code | O=C1N(CC2)C(C3=C2C=C4C(OCO4)=C3)=CC5=C1C(OC)=C(OC)C=C5 | 
| MDL No. | MFCD00189453 | 
| 别名 | 8-Oxoberberine; Berlambine; 8-Oxyberberine; Ketoberberine; NSC 93138; JKL 1073A; Oxyberberin | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 16 mg/mL(45.54 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1